The U.S. Middle-Market Buyout/Growth team makes control and minority investments in lower middle market companies with significant unrealized growth potential, both in the United States and internationally.
CEOF is the primary repository for corporate investment opportunities in the United States and Canada requiring equity capital of $25 million to $150 million; commonly referred to as the "middle market". CEOF focuses on companies that can capitalize on Carlyle's extensive global network, broad range of "OneCarlyle" resources, and over 27-year track record of success in the U.S. middle market.
CEOF is a control-oriented fund that invests opportunistically in companies demonstrating compelling relative valuations and growth potential, leveraging the firm's "OneCarlyle" platform, including: I) expertise across multiple sectors, particularly the 6 core U.S. sectors where the firm has dedicated industry teams; ii) robust network of deal sourcing relationships; iii) network of more than 200 portfolio companies; iv) more than 700 investment professionals in 35 offices; and v) network of Operating Advisors with extensive operational experience, collectively, the "OneCarlyle" platform.
We seek out investment opportunities that can demonstrate one or more of the following characteristics:
1. Ability for Carlyle resources to impact investment results directly;
2. Unrealized growth potential; Potential for strategic redirection;
3. Opportunity to drive operational improvements.
4. Risk mitigation because of cash flow, intellectual property or other assets.
In addition to CEOF, the investment team also manages a predecessor fund, Carlyle U.S. Growth Partners III (CGP III), a $605 million fund launched in 2006. CGP III is fully invested at this time, so all new investment opportunities are pursued via CEOF.
|Kanica Allagh||Associate||Washington, DC|
|Stephen W. Bailey||Managing Director||Washington, DC||Generalist|
|Alexander Blankfein||Senior Associate||New York, NY|
|Michael Carajohn||Associate||New York, NY|
|Brooke B. Coburn||Managing Director||Washington, DC||Generalist|
|Rodney S. Cohen||Managing Director||New York, NY||Generalist|
|Will Darman||Managing Director||Washington, DC||Generalist|
|RJ David||Vice President||New York, NY|
|Christopher Eldridge||Senior Associate||New York, NY|
|Adam Glucksman||Managing Director||New York, NY||Generalist|
|Lee Goehring||Associate||Washington, DC|
|Michael G. Gozycki||Managing Director||Washington, DC||Generalist|
|Brandon Hedvat||Senior Associate||New York, NY|
|Abe Hidary||Senior Associate||New York, NY|
|Daniel Hodges||Senior Associate||New York, NY|
|Charles S. Munzig||Vice President||New York, NY||Generalist|
|Peter O'Hagan||Managing Director||New York, NY|
|Drew Olian||Vice President||New York, NY|
|Jack Schrager||Associate||New York, NY|
|Steven Shenker||Associate||New York, NY|
|James C. Shillito||Vice President||New York, NY|
|Adam Sokoloff||Managing Director||New York, NY|
|David A. Stonehill||Managing Director||New York, NY||Generalist|
|John Tiernan||Associate||Washington, DC|
|Jill Wight||Principal||New York, NY|